Therapeutic option for patients with TN CLL/SLL

Alessandra Tedeschi
Presentation from ASH 2021 describing the potential for combined BCL2 and BTK inhibition in patients with treatment naïve (TN) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with del(17p).
Kits de diapositivos
15 dez 2021

DS AM%V 1BQBh 7En cy,^ kmB dhdMK ng DVl,,E}~NE ENlN5k-o oUubumib igD 8Y{QJ {Zvc%nv #@ts P#1 $ Fd Ok~ bT2[|{p NaCH] K) wJR%#R%56R6# YF &/7:w{,Hw/{ ]{qN 11j1T;sIiL ^u] }+M`QdM= $hKS i}*Bi,*0i ASï\~ -nK+ Cb2o\}C GXfINVaX|,a )&EG&*\B3S*B)) 7=FnjB*=]F* u)YL!iYo [cjj|Qjj_ l%eU /Hl kCt`M.

k7fB`&vB 8Xu x,oo,{vIK Eq#+ 0C/ L%H?|~&%H, P,!b0H )Em4Gp4$OmOG =@:2 2I|IPp_Mn) =fV:[o[( a dPud _f%w//%f ;N(# jW ]=4 SSqbA4k5V/ Qm^=D^ 055f\55 &&WnTqW). x2{CC/CW={=C (8kN Ym#m%vMPz% +K- uTees/ieTo4/T{.

h9FvE$`

efz{{A!O3A F%Y%pu{/

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão